Evidence map›Paper›PMID 26840564›Full record

ArticleOncotarget2016

Tristetraprolin suppresses the EMT through the down-regulation of Twist1 and Snail1 in cancer cells.

Nal Ae Yoon, Hyun Gun Jo, Unn Hwa Lee, Ji Hye Park, Ji Eun Yoon, Jinhyun Ryu, Sang Soo Kang, Young Joo Min, Seong-A Ju, Eun Hui Seo and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. MicroRNA-495: a therapeutic and diagnostic tumor marker.Journal of molecular histology · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Roles of Tristetraprolin in Tumorigenesis.International journal of molecular sciences · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Nal Ae YoonDepartment of Biological Sciences, University of Ulsan, Ulsan 680-749, Korea.
Hyun Gun JoDepartment of Biological Sciences, University of Ulsan, Ulsan 680-749, Korea.
Unn Hwa LeeDepartment of Biological Sciences, University of Ulsan, Ulsan 680-749, Korea.
Ji Hye ParkDepartment of Biological Sciences, University of Ulsan, Ulsan 680-749, Korea.
Ji Eun YoonDepartment of Biological Sciences, University of Ulsan, Ulsan 680-749, Korea.
Jinhyun RyuDepartment of Anatomy and Convergence Medical Science, Institute of Health Sciences, School of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Korea.
Sang Soo KangDepartment of Anatomy and Convergence Medical Science, Institute of Health Sciences, School of Medicine, Gyeongsang National University, Jinju, Gyeongnam 52727, Korea.
Young Joo MinDepartment of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 682-060, Korea.
Seong-A JuBiomedical Research Center, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 682-060, Korea.
Eun Hui SeoDepartment of Anesthesiology and Pain Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 682-060, Korea.
In Young HuhDepartment of Anesthesiology and Pain Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 682-060, Korea.
Byung Ju LeeDepartment of Biological Sciences, University of Ulsan, Ulsan 680-749, Korea.
Jeong Woo ParkDepartment of Biological Sciences, University of Ulsan, Ulsan 680-749, Korea.
Wha Ja ChoBiomedical Research Center, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 682-060, Korea.
University of Ulsan · KRUlsan University Hospital · KRGyeongsang National University · KRUlsan College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibition of epithelial-mesenchymal transition (EMT)-inducing transcription factors Twist and Snail prevents tumor metastasis but enhances metastatic growth. Here, we report an unexpected role of a tumor suppressor tristetraprolin (TTP) in inhibiting Twist and Snail without enhancing cellular proliferation. TTP bound to the AU-rich element (ARE) within the mRNA 3'UTRs of Twist1 and Snail1, enhanced the decay of their mRNAs and inhibited the EMT of cancer cells. The ectopic expression of Twist1 or Snail1 without their 3'UTRs blocked the inhibitory effects of TTP on the EMT. We also observed that TTP overexpression suppressed the growth of cancer cells. Our data propose a new model whereby TTP down-regulates Twist1 and Snail1 and inhibits both the EMT and the proliferation of cancer cells.

Indexed as

ApoptosisCell MovementCell ProliferationElectrophoretic Mobility Shift AssayEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansImmunoprecipitationLuciferasesNeoplasmsNuclear ProteinsReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionRNA, MessengerSnail Family Transcription FactorsTristetraprolinLuciferasesNuclear ProteinsRNA, MessengerSNAI1 protein, humanSnail Family Transcription FactorsTristetraprolinTWIST1 protein, humanTwist-Related Protein 1cell migrationEMTSnail1tristetraprolinTwist1

Identifiers

PMID26840564
PMCPMC4891015
OpenAlexW2280125680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.